Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
8.7%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 0.2Close
$ 0.04 - $ 0.84 52-Week Range
Ticker Information
Ticker
ADAPCompany Name
ADAPTIMMUNE THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQADAPTIMMUNE THERAPEUTICS PLC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ADAP - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 5.67M | 8.7% | $ 65.08M |
| 3/31/2025 | $ 5.23M | 2.91% | $ 179.64M |
| 12/31/2024 | $ 3.35M | 1.88% | $ 178.03M |
| 9/30/2024 | $ 1.64M | 0.93% | $ 175.04M |
| 6/30/2024 | $ 526K | 0.37% | $ 141.46M |
| 3/31/2024 | $ 0 | 0% | $ 18.36M |
| 12/31/2023 | $ 0 | 0% | $ 60.28M |
| 9/30/2023 | $ 0 | 0% | $ 71.08M |
| 6/30/2023 | $ 0 | 0% | $ 70.77M |
| 3/31/2023 | $ 0 | 0% | $ 71.17M |
Key Performance Insights, Last 5 Years
- ADAPTIMMUNE THERAPEUTICS PLC's latest trailing twelve months (TTM) Int. Exp. % stands at 0%.
- Over the past 5 years, ADAPTIMMUNE THERAPEUTICS PLC's average Int. Exp. % has been 0.74%.
- The median Int. Exp. % for ADAPTIMMUNE THERAPEUTICS PLC during this period was 0%
- ADAPTIMMUNE THERAPEUTICS PLC reached its highest Int. Exp. % over the past 5 years at 8.7%.
- The lowest Int. Exp. % recorded by ADAPTIMMUNE THERAPEUTICS PLC in the same timeframe 0%
ADAPTIMMUNE THERAPEUTICS PLC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for ADAPTIMMUNE THERAPEUTICS PLC is calculated as follows: Int. Exp. [ $ 0 ] / Revenues [ $ 3.18M ]
(=) Int. Exp. % [ 0% ] ADAP - Interest Expense Margin, Last 5 years
0%
Minimum
Sep 30, 2020
8.7%
Maximum
Jun 30, 2025
0.74%
Average
0%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.63% with a standard deviation of 2.2%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.49% |
| average | 1.63% |
| median | 0.79% |
| std | 2.2% |